Genmab A/S 2020 SR
The report highlights Genmab's commitment to creating innovative antibody products to improve the lives of cancer patients. In 2020, the company embarked on a more focused corporate social responsibility strategy, aligning with UN Sustainable Development Goals 3, 5, and 8. Key achievements include the launch of a global Diversity and Inclusion Council, an 86% employee engagement score, and the adoption of the SASB framework for ESG disclosures. Genmab also established its first site-based employee-led environmental sustainability working group in the Netherlands and maintained a strong gender balance with 49% female representation at the director level and above.
Company: Genmab A/S
Sector: Professional & technical services
Country: Denmark
Year: 2020
Type: SR
Pages: 26
Back to company
Genmab A/S
Corporate Social Responsibility Report
The report highlights Genmab's commitment to creating innovative antibody products to improve the lives of cancer patients. In 2020, the company embarked on a more focused corporate social responsibility strategy, aligning with UN Sustainable Development Goals 3, 5, and 8. Key achievements include the launch of a global Diversity and Inclusion Council, an 86% employee engagement score, and the adoption of the SASB framework for ESG disclosures. Genmab also established its first site-based employee-led environmental sustainability working group in the Netherlands and maintained a strong gender balance with 49% female representation at the director level and above.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees